Make a donation

Monday, July 24 2017

Myeloma Matters : July 2017

  • Participation in Clinical Trials: The Key to Improving Patient Outcomes
  • MCRN 005 The BOSTON Study Has Officially Begun Recruiting Patients in Canada for the Pivotal Phase III Clinical Trial
  • ASCO 2017: Early BCMA CAR T-Cell Therapy Results Look Promising
  • CBC Health Interviews Dr Vincent Rajkumar on Suspension of Pembrolizumab (Keytruda) Trials in Multiple Myeloma
  • Spotlight on Rolland Manning : A Caregiver's Story
  • Myeloma Canada Educational Webinar : Managing Side Effects
  • Recommendations on Proposed Amendments to the Patented Medicines Regulations
  • Myeloma Canada Issues a Press Release to Bring Awareness and Drive Change in Canadian Oncology Drug Policies
  • Your Nurse, Your Hero
  • In the Community